{
    "organizations": [],
    "uuid": "502a4dc0eed04348c7aba4f5d98443dcc16c37af",
    "author": "",
    "url": "https://www.reuters.com/article/brief-arrowhead-receives-regulatory-clea/brief-arrowhead-receives-regulatory-clearance-to-begin-phase-1-2-study-of-aro-hbv-for-treatment-of-hepatitis-b-idUSFWN1Q510H",
    "ord_in_thread": 0,
    "title": "BRIEF-Arrowhead Receives Regulatory Clearance To Begin Phase 1/2 Study Of Aro-Hbv For Treatment Of Hepatitis B",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 15, 2018 / 12:38 PM / Updated 5 minutes ago BRIEF-Arrowhead Receives Regulatory Clearance To Begin Phase 1/2 Study Of Aro-Hbv For Treatment Of Hepatitis B Reuters Staff 1 Min Read Feb 15 (Reuters) - Arrowhead Pharmaceuticals Inc: * ARROWHEAD RECEIVES REGULATORY CLEARANCE TO BEGIN PHASE 1/2 STUDY OF ARO-HBV FOR TREATMENT OF HEPATITIS B Source text for Eikon: Further company coverage:",
    "published": "2018-02-15T14:35:00.000+02:00",
    "crawled": "2018-02-15T14:54:49.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "receives",
        "regulatory",
        "clearance",
        "begin",
        "phase",
        "study",
        "treatment",
        "hepatitis",
        "b",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "arrowhead",
        "pharmaceutical",
        "inc",
        "arrowhead",
        "receives",
        "regulatory",
        "clearance",
        "begin",
        "phase",
        "study",
        "treatment",
        "hepatitis",
        "b",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}